Compugroup Medical SE (COP) Receives Consensus Rating of “Buy” from Analysts

Compugroup Medical SE (ETR:COP) has been assigned a consensus recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is €58.17 ($69.25).

COP has been the topic of several recent research reports. Baader Bank set a €52.00 ($61.90) price target on Compugroup Medical and gave the stock a “neutral” rating in a report on Tuesday, December 19th. Berenberg Bank set a €53.00 ($63.10) target price on Compugroup Medical and gave the company a “neutral” rating in a research report on Friday, December 15th. Warburg Research set a €56.00 ($66.67) target price on Compugroup Medical and gave the company a “buy” rating in a research report on Thursday, December 14th. Commerzbank set a €62.00 ($73.81) target price on Compugroup Medical and gave the company a “buy” rating in a research report on Thursday, December 14th. Finally, Deutsche Bank set a €65.00 ($77.38) price objective on Compugroup Medical and gave the stock a “buy” rating in a research report on Tuesday, November 14th.

Compugroup Medical (ETR:COP) traded up €1.98 ($2.36) during trading on Tuesday, hitting €56.70 ($67.50). The stock had a trading volume of 56,898 shares, compared to its average volume of 59,280. Compugroup Medical has a 1-year low of €36.12 ($43.00) and a 1-year high of €57.70 ($68.69). The stock has a market capitalization of $2,910.00 and a PE ratio of 69.15.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://transcriptdaily.com/2018/01/02/compugroup-medical-se-cop-receives-consensus-rating-of-buy-from-analysts.html.

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply